{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:48:00Z","timestamp":1792320480778,"version":"4.4.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Drug-induced liver injury (DILI) is one of the serious adverse drug reactions (ADRs), which belongs to immune-mediated adverse drug reactions (IM-ADRs). As an essential health drug, albendazole has rarely been reported to cause serious liver damage. A young man in his 30\u00a0s developed severe jaundice, abnormal transaminases, and poor blood coagulation mechanism after taking albendazole, and eventually developed into severe liver failure. The patient was found heterozygous of <jats:italic>HLA-B*15:02<\/jats:italic> and <jats:italic>HLA-B*13:01<\/jats:italic> through HLA-targeted sequencing, which may have a pathogenic role in the disease. This case report summarizes his presentation, treatment, and prognosis. A useful summary of the diagnosis and associated genetic variant information is provided.<\/jats:p>","DOI":"10.3389\/fphar.2023.1288068","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:59:11Z","timestamp":1699844351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02\/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature"],"prefix":"10.3389","volume":"14","author":[{"given":"Jin-Mao","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.6002\/ect.2015.0313","article-title":"Drug-induced liver failure requiring liver transplant: report and review of the role of albendazole in managing echinococcal infection","volume":"16","author":"Aasen","year":"2018","journal-title":"Exp. Clin. Transpl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tips.2016.11.003","article-title":"Genomics of adverse drug reactions","volume":"38","author":"Alfirevic","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1345\/aph.1D325","article-title":"Adverse drug reactions to anthelmintics","volume":"38","author":"Bagheri","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/00365548.2013.835068","article-title":"Albendazole-induced associated acute hepatitis and bicytopenia","volume":"46","author":"Ben Fredj","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"B5","first-page":"309","article-title":"Albendazole induced recurrent acute toxic hepatitis: a case report","volume":"80","author":"Bilgic","year":"2017","journal-title":"Acta Gastroenterol. Belg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3238\/arztebl.2018.0501","article-title":"Drug hypersensitivity","volume":"115","author":"Bohm","year":"2018","journal-title":"Dtsch. Arztebl Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1468-3083.2008.02988.x","article-title":"Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype","volume":"23","author":"Chen","year":"2009","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3346\/jkms.2008.23.5.903","article-title":"Acute drug-induced hepatitis caused by albendazole","volume":"23","author":"Choi","year":"2008","journal-title":"J. Korean Med. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/cpt.2343","article-title":"Immunopharmacogenomics: mechanisms of HLA-associated drug reactions","volume":"110","author":"Deshpande","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"115826","DOI":"10.1016\/j.carbpol.2019.115826","article-title":"Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis","volume":"232","author":"Eid","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e40080","DOI":"10.2196\/40080","article-title":"Reporting, monitoring, and handling of adverse drug reactions in Australia: scoping review","volume":"9","author":"Fossouo Tagne","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/bcp.13294","article-title":"Pharmacogenomics of off-target adverse drug reactions","volume":"83","author":"Garon","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0169-4758(90)90228-v","article-title":"The metabolism of benzimidazole anthelmintics","volume":"6","author":"Gottschall","year":"1990","journal-title":"Parasitol. Today"},{"key":"B18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4318\/tjg.2013.0426","article-title":"Albendazole-induced toxic hepatitis: a case report","volume":"24","author":"Gozukucuk","year":"2013","journal-title":"Turk J. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans","volume":"21","author":"Kang","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev-pharmtox-010818-021818","article-title":"Applications of immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions","volume":"59","author":"Karnes","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/FPC.0000000000000153","article-title":"Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions","volume":"25","author":"Kongpan","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","article-title":"Drug-induced liver injury","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1289\/ehp.10325","article-title":"HLA-B*1301 as a biomarker for genetic susceptibility to hypersensitivity dermatitis induced by trichloroethylene among workers in China","volume":"115","author":"Li","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1752-1947-7-201","article-title":"Albendazole-induced granulomatous hepatitis: a case report","volume":"7","author":"Marin Zuluaga","year":"2013","journal-title":"J. Med. Case Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s13312-013-0285-8","article-title":"Correspondence","volume":"50","author":"Nandi","year":"2013","journal-title":"Indian Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1097\/MJT.0000000000001341","article-title":"Albendazole-induced liver injury","volume":"28","author":"Piloiu","year":"2021","journal-title":"Am. J. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2125.2000.00170.x","article-title":"Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes","volume":"49","author":"Rawden","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.13183","article-title":"HLAs: key regulators of T-cell-mediated drug hypersensitivity","volume":"91","author":"Redwood","year":"2018","journal-title":"HLA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12911-016-0265-8","article-title":"How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis","volume":"16","author":"Ribeiro-Vaz","year":"2016","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"B33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.25100\/cm.v44i2.1021","article-title":"Albendazole-induced liver injury: a case report","volume":"44","author":"Rios","year":"2013","journal-title":"Colomb. Med. (Cali)."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/s0140-6736(82)92500-4","article-title":"Accelerated development of alcoholic cirrhosis in patients with HLA-B8","volume":"1","author":"Saunders","year":"1982","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7869\/tg.2012.90","article-title":"Recurrent acute hepatitis caused by albendazole","volume":"34","author":"Shah","year":"2013","journal-title":"Trop. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1742-7843.2011.00681.x","article-title":"Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population","volume":"109","author":"Shi","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1200\/JCO.2010.31.3197","article-title":"HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer","volume":"29","author":"Spraggs","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/FPC.0000000000000306","article-title":"Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population","volume":"27","author":"Tempark","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1399-0039.2007.00932.x","article-title":"HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China","volume":"70","author":"Trachtenberg","year":"2007","journal-title":"Tissue Antigens"},{"key":"B42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1399-0039.2009.01237.x","article-title":"Distribution of HLA-A, -B, -Cw, and -DRB1 alleles and haplotypes in an isolated Han population in Southwest China","volume":"73","author":"Yao","year":"2009","journal-title":"Tissue Antigens"},{"key":"B44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12016-014-8418-y","article-title":"Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review","volume":"48","author":"Yip","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1288068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:59:14Z","timestamp":1699844354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1288068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":45,"alternative-id":["10.3389\/fphar.2023.1288068"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1288068","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"article-number":"1288068"}}